Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

bavarian nordic a/s - BVNRY

BVNRY

Close Chg Chg %
9.70 0.07 0.75%

Pre-Market

9.77

+0.07 (0.75%)

Volume: 273.00

Last Updated:

Mar 26, 2026, 3:19 PM EDT

Trade Now

Company Overview: bavarian nordic a/s - BVNRY

BVNRY Key Data

Open

$9.67

 Day Range

9.67 - 9.77

52 Week Range

6.60 - 13.00

 Market Cap

$2.30B

Shares Outstanding

234.81M

 Public Float

N/A

Beta

1.59

 Rev. Per Employee

N/A

P/E Ratio

11.04

 EPS

$0.90

Yield

0.00%

 Dividend

$0.54

EX-DIVIDEND DATE

Mar 27, 2020

 SHORT INTEREST

N/A

AVERAGE VOLUME

1.72K

  

BVNRY Performance

1 Week
 
 0.46%
 
1 Month
 
 -5.49%
 
3 Months
 
 -2.25%
 
1 Year
 
 28.05%
 
5 Years
 
 N/A
 

BVNRY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About bavarian nordic a/s - BVNRY

Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.

BVNRY At a Glance

Bavarian Nordic A/S
Philip Heymans Alle 3
Hellerup, Capital Region 2900
Phone 45-33-26-83-83 Revenue 933.16M
Industry Biotechnology Net Income 207.98M
Sector Health Technology 2025 Sales Growth 12.676%
Fiscal Year-end 12 / 2026 Employees 1,795
View SEC Filings

BVNRY Valuation

P/E Current 11.037
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 11.258
Price to Sales Ratio 2.509
Price to Book Ratio 1.161
Price to Cash Flow Ratio 5.69
Enterprise Value to EBITDA 7.433
Enterprise Value to Sales 1.97
Total Debt to Enterprise Value 0.011

BVNRY Efficiency

Revenue/Employee 519,869.063
Income Per Employee 115,866.728
Receivables Turnover 6.936
Total Asset Turnover 0.429

BVNRY Liquidity

Current Ratio 4.217
Quick Ratio 2.644
Cash Ratio 2.087

BVNRY Profitability

Gross Margin 47.393
Operating Margin 14.921
Pretax Margin 29.184
Net Margin 22.288
Return on Assets 9.558
Return on Equity 11.529
Return on Total Capital 10.174
Return on Invested Capital 11.448

BVNRY Capital Structure

Total Debt to Total Equity 1.017
Total Debt to Total Capital 1.007
Total Debt to Total Assets 0.875
Long-Term Debt to Equity 0.663
Long-Term Debt to Total Capital 0.657
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Bavarian Nordic A/s - BVNRY

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
445.12M 1.02B 828.18M 933.16M
Sales Growth
+48.12% +130.05% -19.12% +12.68%
Cost of Goods Sold (COGS) incl D&A
211.37M 367.90M 431.65M 490.91M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
56.40M 80.36M 90.62M 108.03M
Depreciation
- - - -
-
Amortization of Intangibles
- - - -
-
COGS Growth
-2.67% +74.05% +17.33% +13.73%
Gross Income
233.74M 656.09M 396.53M 442.26M
Gross Income Growth
+180.45% +180.69% -39.56% +11.53%
Gross Profit Margin
+52.51% +64.07% +47.88% +47.39%
2022 2023 2024 2025 5-year trend
SG&A Expense
243.74M 438.81M 261.04M 303.02M
Research & Development
166.23M 320.44M 122.12M 117.03M
Other SG&A
77.51M 118.37M 138.92M 185.98M
SGA Growth
+81.62% +80.03% -40.51% +16.08%
Other Operating Expense
- - - -
-
Unusual Expense
36.27M 5.99M 9.64M (6.74M)
EBIT after Unusual Expense
(46.27M) 211.30M 125.85M 145.97M
Non Operating Income/Expense
1.77M 6.05M 17.02M 128.35M
Non-Operating Interest Income
2.76M 7.92M 7.01M 5.58M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
2.35M 2.18M 2.00M 1.99M
Interest Expense Growth
-19.99% -7.25% -8.17% -0.77%
Gross Interest Expense
2.35M 2.18M 2.00M 1.99M
Interest Capitalized
- - - -
-
Pretax Income
(46.85M) 215.17M 140.87M 272.34M
Pretax Income Growth
+35.14% +559.30% -34.53% +93.33%
Pretax Margin
-10.52% +21.01% +17.01% +29.18%
Income Tax
2.23M 1.13M (2.41M) 64.35M
Income Tax - Current - Domestic
2.23M 226.93K 1.17M 17.44M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- 898.15K (3.58M) 46.92M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(49.07M) 214.05M 143.28M 207.98M
Minority Interest Expense
- - - -
-
Net Income
(49.07M) 214.05M 143.28M 207.98M
Net Income Growth
+33.56% +536.16% -33.06% +45.16%
Net Margin Growth
-11.03% +20.90% +17.30% +22.29%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(49.07M) 214.05M 143.28M 207.98M
Preferred Dividends
- - - -
-
Net Income Available to Common
(49.07M) 214.05M 143.28M 207.98M
EPS (Basic)
-0.2323 0.9301 0.6115 0.8885
EPS (Basic) Growth
+40.47% +500.39% -34.25% +45.30%
Basic Shares Outstanding
211.26M 230.13M 234.31M 234.09M
EPS (Diluted)
-0.2323 0.9301 0.6115 0.8885
EPS (Diluted) Growth
+40.47% +500.39% -34.25% +45.30%
Diluted Shares Outstanding
211.26M 230.13M 234.31M 234.09M
EBITDA
46.40M 297.64M 226.12M 247.26M
EBITDA Growth
+331.31% +541.44% -24.03% +9.35%
EBITDA Margin
+10.42% +29.07% +27.30% +26.50%

Bavarian Nordic A/S in the News